Actogain™ and Monovet® and Tylan™ and MGA®
Veterinary medicine · U.S. Food and Drug Administration, Center for Veterinary Medicine · United States
-
Animal drug application
200651 -
Animal drug product ID
8721
What the source publishes
- Holder
- Huvepharma EOOD
- Active ingredients
- Melengestrol Acetate Monensin Ractopamine Hydrochloride Tylosin
- Form
- Type A medicated articles to be used in the manufacture of Type C medicated feeds
- Routes
- Oral
- Supply regime
- VFD
Names this record is found by
Complete source data
{
"form": "Type A medicated articles to be used in the manufacture of Type C medicated feeds",
"name": "Actogain™ and Monovet® and Tylan™ and MGA®",
"holder": "Huvepharma EOOD",
"routes": [
"Oral"
],
"smpcUrl": null,
"marketed": null,
"useDomain": "veterinary",
"leafletUrl": null,
"supplyRegime": "VFD",
"nativeProduct": {
"routes": [
"Oral"
],
"species": {
"Cattle:699": "Heifers fed in confinement for slaughter"
},
"sortOrder": 1,
"withdrawals": [
"<p>A withdrawal time has not been established for pre-ruminating calves. Do not use in calves to be processed for veal.<br/></p>"
],
"doseFormName": "Type A medicated articles to be used in the manufacture of Type C medicated feeds",
"applicationId": null,
"specifications": "Actogain™: 45.4 g/lb (100 g/kg) of ractopamine hydrochloride, Monovet®: 90.7 g/lb of monensin, Tylan™: 40 g/lb and 100 g/lb of tylosin, and MGA®: 200 mg/lb and 500 mg/lb of melengestrol acetate",
"proprietaryName": "Actogain™ and Monovet® and Tylan™ and MGA®",
"proprietaryNameId": 8721,
"statusDescription": "VFD"
},
"nativeSummary": {
"noohDate": null,
"publishDate": "2020-02-24",
"sponsorName": "Huvepharma EOOD",
"applicationId": 6488,
"applicationType": "A",
"proprietaryName": "Actogain™ and Monovet® and Tylan™ and MGA®\n",
"applicationNumber": 200651,
"activeIngredientName": "Melengestrol Acetate\nMonensin\nRactopamine Hydrochloride\nTylosin\n",
"applicationStatusCode": "A",
"applicationStatusValue": null,
"voluntaryWithdrawalDate": null
},
"targetSpecies": [
{
"code": "699",
"label": "Cattle",
"native": {
"key": "Cattle:699",
"population": "Heifers fed in confinement for slaughter"
},
"sourceId": "us.fda.animal-drugs",
"population": "Heifers fed in confinement for slaughter",
"canonicalId": "cattle",
"mappingStatus": "mapped",
"mappingVersion": 1
}
],
"informationUrl": "https://animaldrugsatfda.fda.gov/adafda/views/#/search",
"ingredientScope": "application-level; no product-specific composition inferred",
"nativePublishDate": "2020-02-24",
"sourceDisposition": "reviewed-veterinary-application-product",
"useDomainEvidence": {
"basis": "publisher-dataset-scope",
"field": "sourceId",
"value": "us.fda.animal-drugs",
"version": 1,
"sourceId": "us.fda.animal-drugs"
},
"withdrawalPeriods": [
{
"native": "<p>A withdrawal time has not been established for pre-ruminating calves. Do not use in calves to be processed for veal.<br/></p>",
"status": "unparsed"
}
],
"patientEligibility": "not-assessed",
"nativeApplicationId": 6488,
"targetSpeciesStatus": "reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"activeIngredientsText": "Melengestrol Acetate\nMonensin\nRactopamine Hydrochloride\nTylosin\n",
"nativeApplicationType": "A",
"applicationIngredients": [
{
"activeIngredientName": "Ractopamine Hydrochloride",
"activeIngredientTolerance": "The tolerance for ractopamine hydrochloride (the marker residue) in swine is 0.15 part per million) in liver (target tissue).<P>\r\n\r\nThe tolerance for ractopamine hydrochloride (the marker residue) in cattle is 0.03 part per million in muscle and 0.09 part per million in liver.<P>\r\n\r\nThe tolerance for ractopamine hydrochloride (the marker residue) in turkeys is 0.45 ppm in liver(target tissue) and 0.1 ppm in muscle.<P>\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t"
},
{
"activeIngredientName": "Melengestrol Acetate",
"activeIngredientTolerance": "A tolerance of 25 parts per billion is established for residues of the parent compound, melengestrol acetate, in fat, of cattle."
},
{
"activeIngredientName": "Tylosin",
"activeIngredientTolerance": "Tolerances are established for residues of tylosin in edible products of animals as follows:\r\n\r\n a. Chickens and turkeys: 0.2 part per \r\nmillion (negligible residue) in uncooked fat, \r\nmuscle, liver, and kidney.\r\n\r\n b. Cattle: 0.2 part per million (negligible \r\nresidue) in uncooked fat, muscle, liver, and \r\nkidney.\r\n\r\n c. Swine: 0.2 part per million (negligible \r\nresidue) in uncooked fat, muscle, liver, and \r\nkidney.\r\n\r\n d. Milk: 0.05 part per million (negligible \r\nresidue).\r\n\r\n e. Eggs: 0.2 part per million (negligible \r\nresidue).\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t"
},
{
"activeIngredientName": "Monensin",
"activeIngredientTolerance": "<p>A tolerance of 0.05 part per million is established for negligible residues of monensin in the edible tissues of cattle and goats. A tolerance for residues of monensin in chickens, turkeys and quail is not needed.</p>"
}
],
"nativeApplicationNumber": 200651,
"nativeProprietaryNameId": 8721,
"restrictionObservations": [
{
"indicationText": "<p>For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to <em>Eimeria bovis </em>and<em> E. zuernii </em>and reduction of incidence of liver abscesses caused by <em>Fusobacterium necrophorum </em>and <em>Arcanobacterium</em> (<em>Actinomyces</em>)<em> pyogenes </em>in cattle fed in confinement for slaughter for the last 28 to 42 days on feed.<br/></p>",
"limitationText": null,
"populationText": "Heifers fed in confinement for slaughter"
},
{
"indicationText": "<p>For increased rate of weight gain, improved feed efficiency and suppression of estrus (heat).<br/></p>",
"limitationText": null,
"populationText": "Heifers fed in confinement for slaughter"
}
],
"withdrawalPeriodsStatus": "reported-unparsed",
"publisherIdentityMeaning": "applicationId/proprietaryNameId are technical website keys; applicationNumber is a separate FDA application reference",
"nativeNoticeOfHearingDate": null,
"nativeApplicationStatusCode": "A",
"nativeVoluntaryWithdrawalDate": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.animal-drugs" \
--data-urlencode "id=us:fda:animaldrugs:6488:8721"